Latest & greatest articles for pulmonary embolism

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pulmonary embolism or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pulmonary embolism and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pulmonary embolism

1. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism

Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism V Venous thromboembolism in o enous thromboembolism in ov ver 16s: er 16s: reducing the risk of hospital-acquired reducing the risk of hospital-acquired deep v deep vein thrombosis or pulmonary ein thrombosis or pulmonary embolism embolism NICE guideline Published: 21 March 2018 nice.org.uk/guidance/ng89 © NICE 2019. All rights reserved. Subject to Notice of rights (https (...) in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 41Contents Contents Overview 5 Who is it for? 5 Recommendations 6 1.1 Risk assessment 6 1.2 Giving information and planning for discharge 8 1.3 All patients 10 1.4 Interventions for people with acute coronary syndromes or acute stroke or for acutely ill patients 12

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

2. Diagnosis and Management of Acute Pulmonary Embolism Full Text available with Trip Pro

Diagnosis and Management of Acute Pulmonary Embolism 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Search Account Menu Menu Navbar Search Filter Mobile Microsite (...) Search Term Close search filter search input Article Navigation Close mobile search navigation Article Navigation Article Contents Article Navigation 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) Stavros V Konstantinides Chairperson Germany/Greece Corresponding authors: Stavros

2019 European Society of Cardiology

3. Pulmonary Embolism Diagnosis and Treatment

Pulmonary Embolism Diagnosis and Treatment ? 2017 Kaiser Foundation Health Plan of Washington. All rights reserved. 1 Pulmonary Embolism Diagnosis & Treatment Guideline Background 2 Evaluation and Diagnosis Adults 3 Pregnant women 4 Adults with cancer 5 Choice of Treatment Setting 6 Subsegmental PE: Treatment Versus Surveillance 8 Treatment with Anticoagulation Medications 9 Recommended testing 9 Choice of anticoagulant medications by population 9 Dosing of anticoagulant medications 11 Duration (...) guideline was developed by Kaiser Permanente Washington (KPWA). 2 Background Pulmonary embolism (PE) is a relatively common vascular disease with potentially life-threatening complications in the short term. The accurate incidence of the condition is unknown, but it is estimated that 200,000 to 500,000 patients are diagnosed with PE each year in the United States. Many of these cases are diagnosed in the emergency department (White 2016). Traditionally, patients with PE are treated in the hospital

2017 Kaiser Permanente Clinical Guidelines

4. Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians

Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians Evaluation of Patients With Suspected Acute Pulmonary Embolism | Annals of Internal Medicine | American College of Physicians '); } '); })(); Sign in below to access your subscription for full content INDIVIDUAL SIGN IN | You will be directed to acponline.org to register and create your Annals account INSTITUTIONAL SIGN (...) IN | | Subscribe to Annals of Internal Medicine . You will be directed to acponline.org to complete your purchase. Search Clinical Guidelines | 3 November 2015 Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians Free Ali S. Raja, MD; Jeffrey O. Greenberg, MD; Amir Qaseem, MD, PhD, MHA; Thomas D. Denberg, MD, PhD; Nick Fitterman, MD; Jeremiah D. Schuur, MD, MHS; for the Clinical Guidelines Committee

2015 American College of Physicians

5. Diagnosis and Management of Acute Pulmonary Embolism

Diagnosis and Management of Acute Pulmonary Embolism ESC GUIDELINES 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS) Authors/Task Force Members: Stavros V. Konstantinides * (Chairperson) (Germany/ Greece), Adam Torbicki * (Co-chairperson) (Poland), Giancarlo Agnelli (Italy), Nicolas Danchin (...) classi?cation of pulmonary embolism severity . . .3039 3. Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3039 3.1 Clinical presentation . . . . . . . . . . . . . . . . . . . . . . . .3039 3.2 Assessment of clinical probability . . . . . . . . . . . . . . . .3040 3.3 D-dimer testing . . . . . . . . . . . . . . . . . . . . . . . . . . .3040 3.4 Computed tomographic pulmonary angiography . . . . . .3042 3.5 Lung scintigraphy

2014 European Society of Cardiology

7. Pulmonary embolism

Pulmonary embolism Evidence Maps - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4

2018 Trip Evidence Maps

8. BTS Guidelines for the outpatient management of pulmonary embolism

BTS Guidelines for the outpatient management of pulmonary embolism Thorax An international journal of RESPIRATORY MEDICINE thorax.bmj.com July 2018 Volume 73 Supplement 2 BRITISH THORACIC SOCIETY GUIDELINE FOR THE INITIAL OUTPATIENT MANAGEMENT OF PULMONARY EMBOLISM British Thoracic Society Outpatient Management of Pulmonary Embolism Guideline Development GroupHealthcare providers need to use clinical judgement, knowledge and expertise when deciding whether it is appropriate to apply (...) recommendations for the management of patients. The recommendations cited here are a guide and may not be appropriate for use in all situations. The guidance provided does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient and/or their guardian or carer.BTS Outpatient Management of Pulmonary Embolism Guideline Development Group Dr Luke Howard (Chair), Dr Steve Barden, Dr Robin Condliffe, Dr Vincent

2018 British Thoracic Society

9. Is long-term Rivaroxaban superior to Warfarin in pulmonary embolism at 6 months?

Is long-term Rivaroxaban superior to Warfarin in pulmonary embolism at 6 months? BestBets: Is long-term Rivaroxaban superior to Warfarin in pulmonary embolism at 6 months? Is long-term Rivaroxaban superior to Warfarin in pulmonary embolism at 6 months? Report By: Chris Morgan - Medical Student Y5 Search checked by Rick Body - Consultant in Emergency Medicine Institution: University of Manchester, Manchester, UK Original institution: Manchester Royal Infirmary Date Submitted: 21st October 2015 (...) Date Completed: 21st October 2015 Last Modified: 21st October 2015 Status: Green (complete) Three Part Question In [patients with proven pulmonary embolism (PE)] is [Rivaroxaban better than warfarin] at [reducing mortality and recurrence of venous thromboembolism at 6 months]? Clinical Scenario A 52-year-old lady has presented to the Emergency Department with a suspected PE. This is confirmed by CT pulmonary angiography (CTPA). Consequently she requires anticoagulation. Hospital guidelines suggest

2015 BestBETS

11. Pulmonary embolism

Pulmonary embolism Pulmonary embolism - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Pulmonary embolism Last reviewed: February 2019 Last updated: July 2018 Summary Pulmonary embolism (PE) is a life-threatening condition resulting from dislodged thrombi occluding the pulmonary vasculature; right heart failure and cardiac arrest may ensue if not aggressively treated. Symptoms include chest pain, dyspnoea, and a sense (...) , and supportive care. For those at intermediate risk of a poor outcome, anticoagulation and ongoing monitoring is required and rescue re-perfusion should be considered. Ongoing anticoagulation therapy is indicated to reduce the risk of recurrent events or fatal PE. Definition Pulmonary embolism (PE) is a consequence of thrombus formation within a deep vein of the body, most frequently in the lower extremities. Thrombus formation in the venous system occurs as a result of venous stasis, trauma

2018 BMJ Best Practice

12. Pulmonary Embolism (PE): Diagnosis

Pulmonary Embolism (PE): Diagnosis © 2015 Thrombosis Canada Page 1 of 1 PULMONARY EMBOLISM (PE): DIAGNOSIS OBJECTIVE: To provide a diagnostic approach to patients with suspected acute pulmonary embolism (PE). BACKGROUND: Venous thromboembolism (VTE) is a common disease, affecting approximately 1-2 in 1,000 adults per year. Approximately one third of first VTE presentations are due to PE while the remainder is due to deep vein thrombosis (DVT). The diagnosis of PE has increased significantly (...) such as SPECT V/Q, has high sensitivity and specificity in patients with a normal chest X-ray who do not have significant lung disease. V/Q scanning should be considered in patients with renal insufficiency, contrast allergy and in young patients with a normal chest X-ray. © 2015 Thrombosis Canada Page 3 of 3 FIGURE 1: SUGGESTED DIAGNOSTIC ALGORITHM FOR SUSPECTED PULMONARY EMBOLISM * Consideration for thrombolysis without diagnostic test confirmation should be made if the patient has a high clinical

2015 Thrombosis Interest Group of Canada

13. Lixiana (edoxaban) - for the prevention of embolism in patients with nonvalvular atrial fibrillation OR treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE.

Lixiana (edoxaban) - for the prevention of embolism in patients with nonvalvular atrial fibrillation OR treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE. Lixiana (edoxaban) × Insert searchphrase to search the website Insert searchphrase to search the website > > > Lixiana (edoxaban) Conclusion Lixiana (edoxaban) is the fourth Non-vitamin K Oral Anticoagulant (NOAC) in Denmark after Eliques (apixaban), Xarelto (rivaroxaban) and Pradaxa (...) (dabigatran). Lixiana is indicated for the prevention of embolism in patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE. For either indication, Lixiana is not inferior to warfarin when it comes to preventing embolism and has a statistically significantly lower occurrence of major bleeding. The lower risk of bleeding is particularly evident in comparisons

2017 Danish Pharmacotherapy Reviews

14. Update: D-dimer Test for Excluding the Diagnosis of Pulmonary Embolism

Update: D-dimer Test for Excluding the Diagnosis of Pulmonary Embolism TAKE-HOME MESSAGE Patients with a low pretest probability for pulmonary embolism according to a structured clinical prediction rule and a negative D-dimer result are unlikely to have pulmonary embolism, particularly among those younger than 65 years. Update: D-dimer Test for Excluding the Diagnosis of Pulmonary Embolism EBEM Commentators Daniel Kwon, BS Lake Erie College of Osteopathic Medicine Erie, PA Melody Milliron, DO (...) -dimer test. Finally, the review is not able to answer questions about the ability of D-dimer to assess for pulmonary embolism in pregnant patients. Appropriate use of advanced radiographic imaging has been highlighted through national effortssuchastheChoosingWisely campaign, which aims to improve patient care by avoiding wasteful or unnecessary medical tests, treatments,andprocedures. 3 Using a negative D-dimer test result for patients with low pretest probability based on a clinical decision rule

2017 Annals of Emergency Medicine Systematic Review Snapshots

15. Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism

Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism Apixaban for the treatment and Apixaban for the treatment and secondary pre secondary prev vention of deep v ention of deep vein ein thrombosis and/or pulmonary embolism thrombosis and/or pulmonary embolism T echnology appraisal guidance Published: 4 June 2015 nice.org.uk/guidance/ta341 © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions (...) due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (TA341) © NICE 2018. All rights reserved

2015 National Institute for Health and Clinical Excellence - Technology Appraisals

16. Combination of Pulmonary Embolism Rule-out Criteria and YEARS Algorithm in a European Cohort of Patients with Suspected Pulmonary Embolism (Abstract)

Combination of Pulmonary Embolism Rule-out Criteria and YEARS Algorithm in a European Cohort of Patients with Suspected Pulmonary Embolism Both the YEARS algorithm and the pulmonary embolism (PE) rule-out criteria (PERC) were created to exclude PE with limited diagnostic tests. A diagnostic strategy combining both scores might save additional computed tomography pulmonary angiography (CTPA) scans, but they have never been evaluated in conjunction.The aim of this study was to determine

2018 EvidenceUpdates

17. Suspected Pulmonary Embolism

Suspected Pulmonary Embolism Revised 2016 ACR Appropriateness Criteria® 1 Suspected Pulmonary Embolism American College of Radiology ACR Appropriateness Criteria ® Suspected Pulmonary Embolism Variant 1: Suspected pulmonary embolism. Intermediate probability with a negative D-dimer or low pretest probability. Radiologic Procedure Rating Comments RRL* X-ray chest 9 ? CTA chest with IV contrast 5 This procedure should be optimized for pulmonary arterial enhancement. This procedure may (...) contrast 2 O US echocardiography transthoracic resting 2 O CT chest without and with IV contrast 1 ??? Arteriography pulmonary with right heart catheterization 1 ???? MRA chest without IV contrast 1 O US echocardiography transesophageal 1 O Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate *Relative Radiation Level ACR Appropriateness Criteria ® 2 Suspected Pulmonary Embolism Variant 2: Suspected pulmonary embolism. Intermediate probability with a positive

2016 American College of Radiology

18. Anticoagulant treatment for subsegmental pulmonary embolism. (Abstract)

Anticoagulant treatment for subsegmental pulmonary embolism. Acute pulmonary embolism (PE) is a common cause of death, accounting for 50,000 to 200,000 deaths annually. It is the third most common cause of mortality among the cardiovascular diseases, after coronary artery disease and stroke.The advent of multi-detector computed tomographic pulmonary angiography (CTPA) has allowed better assessment of PE regarding visualisation of the peripheral pulmonary arteries, increasing its rate (...) PEs. However, the clinical significance in patients and their prognosis have to be studied to evaluate whether anticoagulation therapy is required.This review is an update of a Cochrane systematic review first published in 2014.To assess the effectiveness and safety of anticoagulation therapy versus no intervention in patients with isolated subsegmental pulmonary embolism (SSPE) or incidental SSPE.The Cochrane Vascular Trials Search Co-ordinator searched the Specialised Register (last searched

2016 Cochrane

19. Low-molecular weight heparins versus warfarin for the long-term prevention or treatment of deep vein thrombosis or pulmonary embolism: a review of the clinical and cost-effectiveness

Low-molecular weight heparins versus warfarin for the long-term prevention or treatment of deep vein thrombosis or pulmonary embolism: a review of the clinical and cost-effectiveness Low-molecular weight heparins versus warfarin for the long-term prevention or treatment of deep vein thrombosis or pulmonary embolism: a review of the clinical and cost-effectiveness Low-molecular weight heparins versus warfarin for the long-term prevention or treatment of deep vein thrombosis or pulmonary embolism (...) : a review of the clinical and cost-effectiveness CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Low-molecular weight heparins versus warfarin for the long-term prevention or treatment of deep vein thrombosis or pulmonary embolism: a review of the clinical and cost-effectiveness. Ottawa: Canadian Agency for Drugs and Technologies

2014 Health Technology Assessment (HTA) Database.

20. Imaging for the exclusion of pulmonary embolism in pregnancy. Full Text available with Trip Pro

Imaging for the exclusion of pulmonary embolism in pregnancy. Pulmonary embolism is a leading cause of pregnancy-related death. An accurate diagnosis in pregnant patients is crucial to prevent untreated pulmonary embolism as well as unnecessary anticoagulant treatment and future preventive measures. Applied imaging techniques might perform differently in these younger patients with less comorbidity and altered physiology, who largely have been excluded from diagnostic studies.To determine (...) the diagnostic accuracy of computed tomography pulmonary angiography (CTPA), lung scintigraphy and magnetic resonance angiography (MRA) for the diagnosis of pulmonary embolism during pregnancy.We searched MEDLINE and Embase until July 2015. We used included studies as seeds in citations searches and in 'find similar' functions and searched reference lists. We approached experts in the field to help us identify non-indexed studies.We included consecutive series of pregnant patients suspected of pulmonary

2017 Cochrane